Innate immune signaling acts cell-autonomously to disrupt insulin signaling in the fat body (60, 61), yet infection and Toll signaling suppress Dilp6 production (15), likely via Toll pathway transcription factors that may predominate over Foxo to regulate Dilp6. The gene discussed is INS; the disease is infection.